Table 1.
Biomarker | Trials | Patients | Results | Potential DX efficiency in cryptogenic stroke |
---|---|---|---|---|
Pentraxin-3 | 1 prospective trial | 382 | Weak predictor of the recurrence of AF | +− |
NLC | 2 retrospective trials | 126/32912 | Useful in predicting stroke in patients with known AF | + |
+−: questionable; +: potentially useful.